Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Menstrual cycle regulation" is the coordination of hormonal and physiological interactions among the hypothalamus, anterior pituitary gland, ovaries, and uterus that control the cyclic process of ovulation and endometrial shedding in females. This regulation involves the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, stimulating the pituitary secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which then prompt the ovaries to produce estrogen and progesterone. These sex steroids direct the growth and regression of the endometrial lining and modulate the feedback to the brain to maintain cyclicity[1][2][4][5][6][7]. Disruptions to these regulatory pathways can lead to a variety of menstrual disorders. For molecular-level drug targeting, the appropriate entities would be: - Gonadotropin-releasing hormone receptor - Follicle-stimulating hormone receptor - Luteinizing hormone receptor - Estrogen receptor - Progesterone receptor "Menstrual cycle regulation" should not be used as a molecular target entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Menstrual cycle regulation.